Trek Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Trek Financial's NVS Position: Q2 2026 in Review
Trek Financial reduced its Novartis (NVS) stake by 11% in Q2 2026, selling an estimated $42.9K and leaving 2,210 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #384.
Trek Financial first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $381K in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Trek Financial held 2,210 shares of Novartis worth $346K as of Q2 2026.
- Trek Financial sold 286 Novartis shares in Q2 2026, an estimated $42.9K.
- Novartis made up 0.02% of Trek Financial's portfolio in Q2 2026, its #384 holding.
- Trek Financial first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
- Trek Financial's Novartis position peaked at $381K in Q1 2026.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.